Epidemiology of leukemias in the population covered by the Intangible Solidarity Health Fund (FISSAL), 2022-2023
Keywords:
Leukemia, Health Insurance, Epidemiology, PeruAbstract
Objective: To characterize leukemia diagnoses in the population covered by the Intangible Solidarity Health Fund (FISSAL) of the Comprehensive Health Insurance (SIS) during the period 2022–2023. The Study: An observational, descriptive study was conducted using secondary data obtained from FISSAL (SIS) in Peru, which includes records of oncologic care provided during 2022 and 2023. Findings: A total of 7 771 diagnoses corresponding to 5 443 patients were analyzed. Acute leukemias were the most prevalent (65.1%), primarily affecting the pediatric population, whereas chronic leukemias showed a marked predominance among adults (80.6%). Variations were observed according to age group and geographic region, as well as a strong concentration of diagnoses in the capital city. Conclusion: These findings highlight the urgent need to decentralize oncohematologic care and to improve the equitable distribution of resources in order to ensure timely diagnosis and effective treatment across all cities in the country.
Downloads
References
1. Brighton SC, Kimtis E. Leukemias. En: Buttaro TM, Trybulski J, Polgar-Bailey P, Sandberg-Cook J (Eds): Primary Care: A Collaborative Practice. 6a ed. St. Louis: Elsevier. 2020:1464-70.
2. Liu W, Fang J, Zhu M, Zhou J, Yuan C. Global, regional, and National burden of childhood leukemia from 1990 to 2021.BMC Pediatr. 2025;25(1):571.doi: 10.1186/s12887-025-05847-7.
3. International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today - Peru Fact Sheet [Internet]. Lyon: World Health Organization; 2022 [citado 2026 Feb 22]. Disponible en: https://gco.iarc.who.int/media/globocan/factsheets/populations/604-peru-fact-sheet.pdf
4. Simbaña-Rivera K, Torres-Roman JS, Julca-Marin D, Guerrero J, Quispe-Vicuña C, Guerrero González JA, et al. Mortality by Childhood Acute Lymphoblastic Leukemia: A Regional Analysis in Peru and Ecuador. Asian Pac J Cancer Prev. 2025;26(8):2879-2887. doi: 10.31557/APJCP.2025.26.8.2879.
5. Gerencia Regional de Salud Lambayeque. La Leucemia representa el 40% de cáncer infantil en el Perú [Internet]. Lambayeque: Ministerio de Salud; 2022 [citado 2025 Oct 30]. Disponible en: https://www.gob.pe/institucion/regionlambayeque-geresa/noticias/1108361-la-leucemia-representa-el-40-de-cancer-infantil-en-el-peru
6. Fondo Intangible Solidario de Salud. Atenciones de Cobertura Oncológica [Internet]. Lima: Plataforma Nacional de Datos Abiertos; 2024 [citado 2026 Feb 23]. Disponible en: http://datosabiertos.gob.pe/dataset/atenciones-de-cobertura-oncol%C3%B3gica-2022-fondo-intangible-solidario-de-salud/resource/7183e93a-8671-4770-9836-81a673059880
7. Ministerio de Salud. Perú invierte más de S/200 millones en medicamentos oncológicos de alto costo en 2025 [Internet]. Lima: MINSA; 23 ago 2025 [citado 2025 Nov 5]. Disponible en: https://www.gob.pe/institucion/minsa/noticias/1232256-peru-invierte-mas-de-s-200-millones-en-medicamentos-oncologicos-de-alto-costo-en-2025
8. Agarwal A, Kekre N, Atkins H, Imsirovic H, Hutton B, Coyle D, et al. Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive Study. Curr Oncol. 2024;31(8):4192-4208. doi: 10.3390/curroncol31080313.
9. Instituto Nacional de Estadística e Informática (INEI). Pobreza monetaria afectó al 27,6% de la población del país en el año 2024 [Internet]. Lima: INEI; 2025 [citado 2025 Nov 3]. Disponible en: https://www.gob.pe/institucion/inei/noticias/1164173-pobreza-monetaria-afecto-al-27-6-de-la-poblacion-del-pais-en-el-ano-2024
10. Instituto Nacional de Salud (Perú). Evaluación de las características de la cobertura de la atención de pacientes oncológicos según información del Seguro Integral de Salud. Subdirección de Investigación en Servicios de Salud. Centro de Evaluación de Tecnologías en Salud, Instituto Nacional de Salud, diciembre de 2024. Serie: Informe Técnico de Evaluación – SDISS. N.º 03-2024
